Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

504 public trials 140 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma

NCT06503211

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: PersonGen.Anke Cellular Therapeutice Co., Ltd. Hefei, Anhui, China

View Trial Details

Recruiting

Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies

NCT06462248

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Prince of Wales Hospital Hong Kong, China

View Trial Details

Recruiting

Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment

NCT06439173

Conditions: Cytopenia, Diffuse Large B Cell Lymphoma, Hematologic Diseases, +14 more
Locations: Complejo Asistencial Universitario de Salamanca Salamanca, Spain

View Trial Details

Recruiting

CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)

NCT06002659

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Karolinska University Hospital Stockholm, Sweden

Uppsala University Hospital Uppsala, Sweden

View Trial Details

Recruiting

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

NCT06180174

Conditions: B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia

NCT06081478

Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Burkitt Lymphoma, +18 more
Locations: Liang Wang Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

NCT05842707

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Shanghai Tongji Hospital, Tongji University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma

NCT05436223

Conditions: B-cell Non-Hodgkin's Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

NCT05338931

Conditions: B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Recruiting

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

NCT03787056

Conditions: Adnexal Diseases, Astrocytoma, B-cell Lymphoma, +89 more
Locations: Service de NEURO-ONCOLOGIE du Groupement Hospitalier EST Bron, France

Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'hôpital de la Croix-Rousse Lyon, France

Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'Hôpital E. Herriot Lyon, France

Service d'Oto-Rhino-Laryngologie de l'Hôpital de la Croix-Rousse Lyon, France

View all 17 locations

View Trial Details